« Older Entries
Nexstim announces the result of its private placement
Thursday, December 17th, 2015
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTIO [...]
Merus Appoints Hui Liu as Chief Business Officer
Wednesday, December 16th, 2015
Novartis Oncology’s Former Global Head of Business Development and Licensing Joins
Immuno-oncology Biotech Company
UTRECHT, The Netherlands, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Merus B.V., a clinical-stag [...]
Affimed Added to NASDAQ Biotech Index®
Monday, December 14th, 2015
Heidelberg, Germany, December 14, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that the C [...]
LSP V company Kuros to combine with Cytos
Thursday, December 3rd, 2015
Cytos Biotechnology and Kuros Biosurgery to combine to create Kuros Biosciences
Combined company aims to be a leader in the field of tissue repair and regeneration
Late-stage clinical pipeline of no [...]
« Older Entries